SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-056906
Filing Date
2022-05-06
Accepted
2022-05-06 13:56:31
Documents
13
Period of Report
2022-05-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2214364d2_8k.htm   iXBRL 8-K 33822
2 EXHIBIT 99.1 tm2214364d2_ex99-1.htm EX-99.1 98519
  Complete submission text file 0001104659-22-056906.txt   335445

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ogn-20220505.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20220505_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20220505_pre.xml EX-101.PRE 22592
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2214364d2_8k_htm.xml XML 3594
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 22900310
SIC: 2834 Pharmaceutical Preparations